Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
20th January 2021 | Oliver Christian Bennett | 4,399 | Open or private sale | $4.49 | $19,752.39 |
13th January 2021 | Hove Caroline F. Van | 1,973 | Open or private sale | $4.71 | $9,300.52 |
12th January 2021 | Keith J Sullivan | 125,000 | Grant/award etc. | $0.00 | |
7th January 2021 | Oliver Christian Bennett | 3,665 | Payment by withholding | $4.26 | $15,612.90 |
11th November 2020 | Kevin C Oboyle | 16,306 | Disposition due to a tender of shares in a change of control transaction | $30.75 | $501,409.50 |
8th November 2020 | Hove Caroline F. Van | 100,000 | Grant/award etc. | $0.00 | |
12th October 2020 | Paul Sean Little | 50,000 | Grant/award etc. | $0.00 | |
12th October 2020 | Oliver Christian Bennett | 50,000 | Grant/award etc. | $0.00 | |
3rd September 2020 | Paul Sean Little | 5,763 | Payment by withholding | $3.54 | $20,401.02 |
14th July 2020 | Keith J Sullivan | 500,000 | Grant/award etc. | $0.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.
Sientra, Inc. engages in developing and commercializing plastic surgery implantable devices. It operates through two reportable segments: Breast Products and miraDry. The Breast Products segment focuses on sales of its breast implants, tissue expanders and scar management products under the brands Sientra,. AlloX2, Dermaspan, Softspan and BIOCORNEUM.
9th November 2020
6th November 2020
6th November 2020